Clearside Biomedical Statistics

Total Valuation

CLSD has a market cap or net worth of $78.88 million. The enterprise value is $106.02 million.

Market Cap	78.88M
Enterprise Value	106.02M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CLSD has 75.84 million shares outstanding. The number of shares has increased by 14.89% in one year.

Current Share Class	75.84M
Shares Outstanding	75.84M
Shares Change (YoY)	+14.89%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	7.41%
Owned by Institutions (%)	21.11%
Float	70.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.60
Forward PS	184.79
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.49

Current Ratio	4.49
Quick Ratio	4.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-48.46%
Return on Capital (ROIC)	-69.81%
Revenue Per Employee	$256,767
Profits Per Employee	-$1.06M
Employee Count	30
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.14% in the last 52 weeks. The beta is 2.33, so CLSD's price volatility has been higher than the market average.

Beta (5Y)	2.33
52-Week Price Change	+10.14%
50-Day Moving Average	1.18
200-Day Moving Average	1.26
Relative Strength Index (RSI)	44.98
Average Volume (20 Days)	312,563

Short Selling Information

The latest short interest is 1.76 million, so 2.32% of the outstanding shares have been sold short.

Short Interest	1.76M
Short Previous Month	1.95M
Short % of Shares Out	2.32%
Short % of Float	2.50%
Short Ratio (days to cover)	1.21

Income Statement

In the last 12 months, CLSD had revenue of $7.70 million and -$31.88 million in losses. Loss per share was -$0.46.

Revenue	7.70M
Gross Profit	7.70M
Operating Income	-24.65M
Pretax Income	-34.97M
Net Income	-31.88M
EBITDA	-24.48M
EBIT	-24.65M
Loss Per Share	-$0.46

Full Income Statement

Balance Sheet

The company has $23.59 million in cash and $49.97 million in debt, giving a net cash position of -$26.38 million or -$0.35 per share.

Cash & Cash Equivalents	23.59M
Total Debt	49.97M
Net Cash	-26.38M
Net Cash Per Share	-$0.35
Equity (Book Value)	-34.79M
Book Value Per Share	-0.47
Working Capital	19.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.95 million and capital expenditures -$653,000, giving a free cash flow of -$19.60 million.

Operating Cash Flow	-18.95M
Capital Expenditures	-653,000
Free Cash Flow	-19.60M
FCF Per Share	-$0.26

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-319.98%
Pretax Margin	-413.84%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-242.42%

Dividends & Yields

CLSD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.89%
Shareholder Yield	-14.89%
Earnings Yield	-40.03%
FCF Yield	-24.61%

Analyst Forecast

The average price target for CLSD is $5.33, which is 412.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.33
Price Target Difference	412.50%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	77.65%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CLSD has an Altman Z-Score of -17.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.63
Piotroski F-Score	3